Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Patent
1978-01-06
1979-03-13
Rush, Raymond V.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
260307DA, 548339, C07D26120, A61K 3142
Patent
active
041443454
ABSTRACT:
Dihydroxybenzisoxazolin-3-yl-substituted-1-methyl-5-nitroimidazoles having the hydroxy- groups on adjacent 4,5-; 5,6- or 6,7-positions of the isoxazolin group. These compounds have antibacterial and antiprotozoal activity in humans and animals. They are particularly active against trypanosomiasis and trichomoniasis.
REFERENCES:
patent: 3711495 (1973-01-01), Kulsa et al.
Morrison et al-"Organic Chemstry"-Allyn & Bacon, Inc. (1959)-p. 651.
Kulsa Peter
Mrozik Helmut H.
Merck & Co. , Inc.
Patton Walter
Rush Raymond V.
Westlake, Jr. Harry E.
LandOfFree
Dihydroxybenzisoxazolin-3-yl-substituted-5-nitroimidazoles as an does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dihydroxybenzisoxazolin-3-yl-substituted-5-nitroimidazoles as an, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dihydroxybenzisoxazolin-3-yl-substituted-5-nitroimidazoles as an will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2371763